Glaucoma:
Indications for: VYZULTA
Open-angle glaucoma. Ocular hypertension.
Adult Dosage:
>16yrs: instill 1 drop in the affected eye(s) once daily in the PM.
Children Dosage:
≤16yrs: not recommended.
VYZULTA Warnings/Precautions:
Do not exceed recommended dose (may reduce efficacy). History of ocular inflammation: not recommended if active inflammation. Aphakia. Pseudophakia with torn posterior lens capsule. Risk of macular edema. Bacterial keratitis may occur (due to multiple-dose containers). Contact lenses (remove; may reinsert lenses 15mins after administration). Pregnancy. Nursing mothers.
VYZULTA Classification:
Prostaglandin analogue.
VYZULTA Interactions:
Allow at least 5mins between application of other topical oph agents.
Adverse Reactions:
Conjunctival hyperemia, eye irritation, eye pain, instillation site pain; increased ocular pigmentation (eg, iris [may be permanent], eyelid, eyelashes), other eyelash/lid changes, macular edema (including cystoid macular edema).
Generic Drug Availability:
NO
How Supplied:
Soln—5mL
